Table 3.
Percentage of patients with coronary heart disease and diabetes whose parameters were at goal before and after program implementation
| Goal parameter | Coronary heart disease | Diabetes | p value: change in CHD vs change in diabetes parameters | ||||
|---|---|---|---|---|---|---|---|
| Pre (n = 511) | Post (n = 529) | p value | Pre (n = 485) | Post (n = 509) | p value | ||
| Blood pressure | 86.6 | 86.8 | 0.9239 | 84.5 | 87.8 | 0.1342 | 0.3129 |
| LDL cholesterol | 77.0 | 83.9 | .0041 | 70.7 | 70.7 | 0.9999 | 0.0323 |
| Aspirin | 65.2 | 97.5 | < 0.0001 | 58.6 | 97.6 | < 0.0001 | 0.3427 |
| Tobacco-free | 79.7 | 81.1 | 0.5562 | 81.2 | 83.3 | 0.3945 | 0.8207 |
| Hemoglobin A1c | NA | NA | NA | 84.7 | 81.3 | 0.1536 | NA |
| Composite score criteriona | 40.3 | 59.9 | < 0.0001 | 24.5 | 45.4 | < 0.0001 | 0.2319 |
a
Composite score for patients with coronary heart disease comprises blood pressure under 140/90 mmHg, low-density-lipoprotein cholesterol level below 100 mg/dL, daily aspirin therapy unless contraindicated, and tobacco-free status. Composite score criterion for patients with diabetes encompasses the same 4 components plus a hemoglobin A1c concentration below 8%.
CHD = coronary heart disease; LDL = low-density-lipoprotein; NA = not applicable; post = postimplementation; pre = preimplementation.